Go Pro
NYSE:AVNS

Avanos Medical (AVNS) Stock Price, News & Analysis

Avanos Medical logo
$24.92 -0.01 (-0.02%)
Closing price 07/2/2026 03:59 PM Eastern
Extended Trading
$24.93 +0.00 (+0.02%)
As of 07/2/2026 06:03 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Avanos Medical Stock (NYSE:AVNS)

Advanced

Key Stats

Today's Range
$24.87
$24.94
50-Day Range
$24.63
$25.09
52-Week Range
$9.30
$25.49
Volume
1.28 million shs
Average Volume
936,805 shs
Market Capitalization
$1.17 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Reduce

Company Overview

Avanos Medical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
9th Percentile Overall Score

AVNS MarketRank™: 

Avanos Medical scored higher than 9% of companies evaluated by MarketBeat, and ranked 834th out of 855 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Avanos Medical has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.

  • Amount of Analyst Coverage

    Avanos Medical has only been the subject of 2 research reports in the past 90 days.

  • Read more about Avanos Medical's stock forecast and price target.
  • Earnings Growth

    Earnings for Avanos Medical are expected to decrease by -11.32% in the coming year, from $1.06 to $0.94 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Avanos Medical is -15.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Avanos Medical is -15.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Avanos Medical has a P/B Ratio of 1.49. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Avanos Medical's valuation and earnings.
  • Percentage of Shares Shorted

    3.74% of the float of Avanos Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Avanos Medical has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Avanos Medical has recently increased by 47.48%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Avanos Medical does not currently pay a dividend.

  • Dividend Growth

    Avanos Medical does not have a long track record of dividend growth.

  • News Coverage This Week

    MarketBeat has tracked 1 news article for Avanos Medical this week, compared to 2 articles on an average week.
  • Search Interest

    1 people have searched for AVNS on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Avanos Medical insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    2.33% of the stock of Avanos Medical is held by insiders.

  • Percentage Held by Institutions

    95.17% of the stock of Avanos Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Avanos Medical's insider trading history.
Receive AVNS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avanos Medical and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AVNS Stock News Headlines

SpaceX IPO hides a much bigger story
The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. Elon believes what Michael Robinson calls 'Project Unlimited' could unlock $100 trillion in potential growth. One little-known company sits at the center of it all, and most investors have no idea it exists. Position yourself before this company potentially hits the front page.tc pixel
Summers Value Partners Q1 2026 Partner Letter
See More Headlines

AVNS Stock Analysis - Frequently Asked Questions

Avanos Medical's stock was trading at $11.23 at the start of the year. Since then, AVNS shares have increased by 122.0% and is now trading at $24.9250.

Avanos Medical, Inc. (NYSE:AVNS) released its quarterly earnings data on Tuesday, May, 5th. The company reported $0.22 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.06. The business's revenue was up 8.8% on a year-over-year basis.

Top institutional investors of Avanos Medical include Samson Rock Capital LLP (1.28%). Insiders that own company stock include Michael Greiner, Gary Blackford, Kerr Holbrook and Julie Ann Shimer.
View institutional ownership trends
.

Shares of AVNS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Avanos Medical investors own include JPMorgan Chase & Co. (JPM), Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), Home Depot (HD), Netflix (NFLX) and Tesla (TSLA).

Company Calendar

Last Earnings
5/05/2026
Today
7/03/2026
Next Earnings (Estimated)
8/04/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NYSE:AVNS
CIK
1606498
Fax
N/A
Employees
2,287
Year Founded
2014

Profitability

EPS (Trailing Twelve Months)
($1.61)
Trailing P/E Ratio
N/A
Forward P/E Ratio
23.51
P/E Growth
N/A
Net Income
-$72.90 million
Net Margins
-10.39%
Pretax Margin
-9.54%
Return on Equity
5.39%
Return on Assets
3.97%

Debt

Debt-to-Equity Ratio
0.11
Current Ratio
2.48
Quick Ratio
1.40

Sales & Book Value

Annual Sales
$701.20 million
Price / Sales
1.67
Cash Flow
$3.47 per share
Price / Cash Flow
7.19
Book Value
$16.73 per share
Price / Book
1.49

Miscellaneous

Outstanding Shares
46,850,000
Free Float
45,756,000
Market Cap
$1.17 billion
Optionable
Optionable
Beta
1.57

Social Links

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

This page (NYSE:AVNS) was last updated on 7/3/2026 by MarketBeat.com Staff.
From Our Partners